{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T15:33:46Z","timestamp":1779204826843,"version":"3.51.4"},"reference-count":39,"publisher":"BMJ","issue":"3","funder":[{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Arch Dis Child"],"published-print":{"date-parts":[[2019,3]]},"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Biannual vitamin A supplementation is a well-established survival tool for preschool children 6 months and older in vitamin A deficient populations but this schedule misses the opportunity to intervene on most young infant deaths. Randomised trials of neonatal vitamin A supplementation (NVAS) in the first few days of life to assess its impact on under 6-month mortality in low\/middle-income countries have had varying results.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Investigators of 11 published randomised placebo-controlled NVAS trials (n=163 567 children) reanalysed their data according to an agreed plan and pooled the primary outcomes of mortality from supplementation through 6 and 12 months of age using random effects models and meta-regression. One investigator withdrew but allowed use of the data.<\/jats:p><\/jats:sec><jats:sec><jats:title>Findings<\/jats:title><jats:p>Overall there was no effect of NVAS on infant survival through 6 (risk ratio (RR) 0.97; 95% CI 0.89 to 1.06) or 12 months of age (RR 1.00; 95% CI 0.93 to 1.08) but results varied by study population characteristics.<\/jats:p><jats:p>NVAS significantly reduced 6-month mortality among the trials conducted in Southern Asia (RR 0.87; 95% CI 0.77 to 0.98), in contexts with moderate or severe vitamin A deficiency (defined as 10% or higher proportion of women with serum retinol &lt;0.7 \u00b5mol\/L or 5% or more women with night blindness) (RR 0.87; 95% CI 0.80 to 0.94), early infant mortality was 30 or more per 1000 live births (RR 0.91; 95% CI 0.85 to 0.98), 75% or more of infant mortality occurred in the first 6 months of life (RR 0.92; 95% CI 0.84 to 1.01), or where &gt;32% mothers had no schooling (RR 0.88; 95% CI 0.80 to 0.96). NVAS did not reduce mortality in the first 6 months of life in trials conducted in Africa, in contexts characterised by a low prevalence of vitamin A deficiency, lower rates of infant mortality and where maternal education was more prevalent. There was a suggestion of increased infant mortality in trials conducted in Africa (RR 1.07; 95% CI 1.00 to 1.15).<\/jats:p><jats:p>Individual-level characteristics such as sex, birth weight, gestational age and size, age at dosing, parity, time of breast feeding initiation, maternal education and maternal vitamin A supplementation did not modify the impact of NVAS.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>NVAS reduced infant mortality in South Asia, in contexts where the prevalence of maternal vitamin A deficiency is moderate to severe and early infant mortality is high; but it had no beneficial effect on infant survival in Africa, in contexts where the prevalence of maternal vitamin A deficiency is lower, early infant mortality is low.<\/jats:p><\/jats:sec>","DOI":"10.1136\/archdischild-2018-315242","type":"journal-article","created":{"date-parts":[[2018,11,13]],"date-time":"2018-11-13T17:19:19Z","timestamp":1542129559000},"page":"217-226","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":27,"title":["Early neonatal vitamin A supplementation and infant mortality: an individual participant data meta-analysis of randomised controlled trials"],"prefix":"10.1136","volume":"104","author":[{"name":"Neonatal Vitamin A Supplementation Evidence group","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2018,11,13]]},"reference":[{"key":"2020050712483245000_104.3.217.1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(15)00120-8"},{"key":"2020050712483245000_104.3.217.2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)60937-X"},{"key":"2020050712483245000_104.3.217.3","first-page":"CD008524","article-title":"Vitamin A supplementation for preventing morbidity and mortality in children from six months to five years of age","volume":"3","author":"Imdad","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050712483245000_104.3.217.4","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.306.6874.366"},{"key":"2020050712483245000_104.3.217.5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.1993.03500070078033"},{"key":"2020050712483245000_104.3.217.6","unstructured":"Beaton GH , Martorell R , Aronson KJ , et al . Effectiveness of Vitamin A Supplementation in the Control of YoungChild Morbidity and Mortality in Developing Countries \u2212 Nutritionpolicy discussion paper No. 13, 1993."},{"key":"2020050712483245000_104.3.217.7","unstructured":"UNICEF. Vitamin A Supplementation: A decade of progress, 2007."},{"key":"2020050712483245000_104.3.217.8","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1093\/ajcn\/85.5.1312","article-title":"Randomized controlled safety and efficacy trial of 2 vitamin A supplementation schedules in Tanzanian infants","volume":"85","author":"Idindili","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"2020050712483245000_104.3.217.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)60981-7"},{"key":"2020050712483245000_104.3.217.10","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1093\/ajcn\/62.1.143","article-title":"Mortality of infants < 6 mo of age supplemented with vitamin A: a randomized, double-masked trial in Nepal","volume":"62","author":"West","year":"1995","journal-title":"Am J Clin Nutr"},{"key":"2020050712483245000_104.3.217.11","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(98)02487-8"},{"key":"2020050712483245000_104.3.217.12","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(96)70359-1"},{"key":"2020050712483245000_104.3.217.13","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2007-3448"},{"key":"2020050712483245000_104.3.217.14","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.327.7409.254"},{"key":"2020050712483245000_104.3.217.15","doi-asserted-by":"publisher","DOI":"10.1086\/500366"},{"key":"2020050712483245000_104.3.217.16","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1093\/ajcn.81.2.454","article-title":"Effect of postpartum maternal or neonatal vitamin A supplementation on infant mortality among infants born to HIV-negative mothers in Zimbabwe","volume":"81","author":"Malaba","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"2020050712483245000_104.3.217.17","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.c1101"},{"key":"2020050712483245000_104.3.217.18","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39542.509444.AE"},{"key":"2020050712483245000_104.3.217.19","doi-asserted-by":"publisher","DOI":"10.3945\/jn.114.192674"},{"key":"2020050712483245000_104.3.217.20","first-page":"CD006980","article-title":"Neonatal vitamin A supplementation for the prevention of mortality and morbidity in term neonates in developing countries","volume":"10","author":"Haider","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050712483245000_104.3.217.21","first-page":"CD007480","article-title":"Vitamin A supplementation for the prevention of morbidity and mortality in infants six months of age or less","volume":"10","author":"Gogia","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050712483245000_104.3.217.22","doi-asserted-by":"crossref","unstructured":"Mazumder S , Taneja S , Bhatia K , et al . Efficacy of early neonatal supplementation with vitamin A to reduce mortality in infancy in Haryana, India (Neovita): a randomised, double-blind, placebo-controlled trial. Lancet 2015;385.doi:10.1016\/S0140-6736(14)60891-6","DOI":"10.1016\/S0140-6736(14)60891-6"},{"key":"2020050712483245000_104.3.217.23","doi-asserted-by":"crossref","unstructured":"Masanja H , Smith ER , Muhihi A , et al . Effect of neonatal vitamin A supplementation on mortality in infants in Tanzania (Neovita): a randomised, double-blind, placebo-controlled trial. Lancet 2015;385.doi:10.1016\/S0140-6736(14)61731-1","DOI":"10.1016\/S0140-6736(14)61731-1"},{"key":"2020050712483245000_104.3.217.24","doi-asserted-by":"crossref","unstructured":"Edmond KM , Newton S , Shannon C , et al . Effect of early neonatal vitamin A supplementation on mortality during infancy in Ghana (Neovita): a randomised, double-blind, placebo-controlled trial. Lancet 2015;385.doi:10.1016\/S0140-6736(14)60880-1","DOI":"10.1016\/S0140-6736(14)60880-1"},{"key":"2020050712483245000_104.3.217.25","doi-asserted-by":"publisher","DOI":"10.1136\/archdischild-2016-310542"},{"key":"2020050712483245000_104.3.217.26","unstructured":"WHO. Serum retinol concentrations for determining the prevalence of vitamin A deficiency in populations. Geneva: World Health Organization, 2011."},{"key":"2020050712483245000_104.3.217.27","unstructured":"WHO. Indicators for assessing vitamin A deficiency and their application in monitoring and evaluating intervention programmes. Geneva: WHO, 1996."},{"key":"2020050712483245000_104.3.217.28","unstructured":"WHO. Global prevalence of vitamin A deficiency in populations at risk 1995\u20132005. WHO Global Database on Vitamin A Deficiency. Geneva: WHO, 2009."},{"key":"2020050712483245000_104.3.217.29","first-page":"CD006980","article-title":"Neonatal vitamin A supplementation for the prevention of mortality and morbidity in term neonates in low and middle income countries","volume":"2","author":"Haider","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050712483245000_104.3.217.30","doi-asserted-by":"crossref","unstructured":"West Jr KP . Public health impact of preventing vitamin A deficiency in the first six months of life: Karger Publishers, 2003.","DOI":"10.1159\/000074712"},{"key":"2020050712483245000_104.3.217.31","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1093\/jn\/137.11.2470","article-title":"Newborn vitamin A dosing reduces the case fatality but not incidence of common childhood morbidities in South India","volume":"137","author":"Tielsch","year":"2007","journal-title":"J Nutr"},{"key":"2020050712483245000_104.3.217.32","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/jn\/132.9.2743","article-title":"Vitamin A deficiency exacerbates inflammation in a rat model of colitis through activation of nuclear factor-kappaB and collagen formation","volume":"132","author":"Reifen","year":"2002","journal-title":"J Nutr"},{"key":"2020050712483245000_104.3.217.33","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/jn\/132.8.2131","article-title":"DNA microarray technology reveals similar gene expression patterns in rats with vitamin a deficiency and chemically induced colitis","volume":"132","author":"Nur","year":"2002","journal-title":"J Nutr"},{"key":"2020050712483245000_104.3.217.34","doi-asserted-by":"crossref","first-page":"2600","DOI":"10.1093\/jn\/136.10.2600","article-title":"Vitamin A supplementation reduces the monocyte chemoattractant protein-1 intestinal immune response of Mexican children","volume":"136","author":"Long","year":"2006","journal-title":"J Nutr"},{"key":"2020050712483245000_104.3.217.35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/jn\/131.2.255","article-title":"Vitamin A supplementation at birth delays pneumococcal colonization in South Indian infants","volume":"131","author":"Coles","year":"2001","journal-title":"J Nutr"},{"key":"2020050712483245000_104.3.217.36","doi-asserted-by":"publisher","DOI":"10.1093\/ije\/dyv117"},{"key":"2020050712483245000_104.3.217.37","first-page":"CD000501","article-title":"Vitamin A supplementation to prevent mortality and short- and long-term morbidity in very low birth weight infants","volume":"22","author":"Darlow","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"2020050712483245000_104.3.217.38","doi-asserted-by":"publisher","DOI":"10.1136\/adc.2004.057547"},{"key":"2020050712483245000_104.3.217.39","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1093\/ije\/dyw238","article-title":"The effect of neonatal vitamin A supplementation on morbidity and mortality at 12 months: a randomized trial","volume":"45","author":"Smith","year":"2016","journal-title":"Int J Epidemiol"}],"container-title":["Archives of Disease in Childhood"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/archdischild-2018-315242","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T22:13:53Z","timestamp":1601072033000},"score":1,"resource":{"primary":{"URL":"https:\/\/adc.bmj.com\/lookup\/doi\/10.1136\/archdischild-2018-315242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11,13]]},"references-count":39,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2019,2,19]]},"published-print":{"date-parts":[[2019,3]]}},"alternative-id":["10.1136\/archdischild-2018-315242"],"URL":"https:\/\/doi.org\/10.1136\/archdischild-2018-315242","relation":{},"ISSN":["0003-9888","1468-2044"],"issn-type":[{"value":"0003-9888","type":"print"},{"value":"1468-2044","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,11,13]]}}}